Restatement of Previously Issued Financial Statements (Details) - Schedule of the company’s previously issued balance	12 Months Ended
	Feb. 28, 2021 USD ($)
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	$ 1,288,107
Note payable	159,922
Derivative warrant liability
Additional paid-in capital	446,126,640
Accumulated deficit	(465,883,499)
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)
Note payable
Derivative warrant liability	1,366,375
Additional paid-in capital	(136,004)
Total liabilities	258,636
Accumulated deficit	(1,366,375)
Total stockholders’ deficit	136,004
Total liabilities and stockholders’ deficit	(258,636)
Reclassifications [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	3,668
Note payable	(3,668)
Derivative warrant liability
Additional paid-in capital
Total liabilities
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	1,291,775
Note payable	156,255
Derivative warrant liability	1,366,375
Additional paid-in capital	446,249,272
Accumulated deficit	$ (467,372,506)